Home
Tech Grid
News Room
Interviews
CISO POV
Think Stack
Articles
  • Enterprise AI

Domino Data Lab and EPAM Partner to Accelerate AI in Life Sciences


 Domino Data Lab and EPAM Partner to Accelerate AI in Life Sciences
  • by: PR Newswire
  • |
  • September 30, 2026

Domino Data Lab, provider of the unified platform to build, scale, and govern enterprise AI solutions, today announced a strategic partnership with EPAM, a leading global AI and digital transformation services company. The collaboration pairs EPAM's custom systems engineering expertise with Domino's platform, helping joint customers deploy GxP-validated AI models and governed enterprise analytics across R&D.

Quick Intel

  • Domino Data Lab and EPAM announce strategic partnership to accelerate AI adoption in life sciences.
  • Combines Domino's enterprise AI platform with EPAM's global engineering and AI/RUN™ frameworks.
  • Targets bottleneck of moving AI models from experimental sandboxes to validated production.
  • Addresses legacy fragmentation, GxP revalidation demands and governance hurdles in biopharma.
  • EPAM and Domino FDEs embed with customer teams to modernize legacy code and ensure compliance.
  • Focus on discovery, statistical computing modernization and scaling real-world evidence across lifecycle.

Bridging the Gap from AI Pilot to Validated Production

While life sciences organizations are eager to scale advanced AI, moving models and applications out of experimental sandboxes into validated production remains a primary bottleneck. Domino's latest industry research identifies legacy system fragmentation, GxP revalidation demands, and governance hurdles as the primary barriers before AI initiatives can deliver impact.

Domino provides the platform layer to bridge these gaps, while EPAM delivers the specialized domain engineering to integrate it into enterprise IT stacks. EPAM's dedicated integration teams and forward-deployed engineering work alongside Domino's FDEs, embedding directly with customer teams to accelerate deployment timelines, modernize legacy code, and ensure strict compliance across heterogeneous IT architectures.

Delivering Solutions Across the Biopharma Lifecycle

Together, EPAM and Domino help leaders advance discovery and target identification by improving candidate selection through AI agents, LLMs, and machine learning pipelines against large-scale genomic datasets.

The partnership also modernizes statistical computing to shorten regulatory submission timelines by giving biostatisticians and statistical programmers a governed environment to unify SAS, R, and Python, from analysis through TFL generation. Additionally, the companies scale real-world evidence by speeding observational research through standardizing massive, heterogeneous real-world data sets on a secure analytics layer.

The collaboration enables pharma organizations to move AI into validated production no matter which team is building it, scaling AI solutions enterprise-wide rather than within a single function.

 

About Domino Data Lab

Domino Data Lab helps the world's most consequential industries turn AI into outcomes that matter. Enterprises transform their business by partnering with Domino to build AI solutions that accelerate innovation and reduce cost, risk, and complexity. The world's largest enterprises trust its platform and expertise for mission-critical AI work. Founded in 2013, Domino is backed by Sequoia Capital, Coatue Management, NVIDIA, NetApp, Snowflake, UBS, and other leading investors.

  • Pharma AIEnterprise AIAIRUN
News Disclaimer
  • Share
Enterprise Tech News